medline.ch Urologie-Nephrologie Tumoren BPH

	Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer. JAMA Oncol Tosoian JJ, Zhang Y, Xiao L, Xie C, Samora NL, Niknafs YS, Chopra Z, Siddiqui J, Zheng H, Herron G, Vaishampayan N, Robinson HS, Arivoli K, Trock BJ, Ross AE, Morgan TM, Palapattu GS, Salami SS, Kunju LP, Tomlins SA, Sokoll LJ, Chan DW, Srivastava S, Feng Z, Sanda MG, Zheng Y, Wei JT, Chinnaiyan AM, EDRN-PCA3 Study Group. PMID: 38635241 [PubMed - as supplied by publisher]
	Radiomics and machine learning for renal tumor subtype assessment using multiphase computed tomography in a multicenter setting. Eur Radiol Uhlig A, Uhlig J, Leha A, Biggemann L, Bachanek S, Stöckle M, Reichert M, Lotz J, Zeuschner P, Maßmann A. PMID: 38634876 [PubMed - as supplied by publisher]
	Radical nephrectomy for a giant chromophobe renal cell carcinoma diagnosed > 17 years previously: a case report and literature review. Front Oncol Lan J, Lan D, Yuan W, Ying Q, He J, Gu Y. PMID: 38634044 [PubMed]
	Patient-centred pathology reporting improves patient experience and understanding of disease in prostate cancer care. BJUI Compass Al Saffar H, Thomson A, Tan JS, Wang Q, Birch E, Koschel S, Medhurst E, Jobson D, Ong S, Moon DA, Murphy D, Lawrentschuk N. PMID: 38633832 [PubMed]
	The impact of pre-biopsy MRI and additional testing on prostate cancer screening outcomes: A rapid review. BJUI Compass Tesfai A, Norori N, Harding TA, Wong YH, Hobbs MD. PMID: 38633829 [PubMed]
	Comparing fluorodeoxyglucose positron emission tomography with computed tomography in staging for nodal and distant metastasis in urothelial/bladder cancer. BJUI Compass Al-Zubaidi M, Ong K, Viswambaram P, Bangash H, Boardman G, McCombie SP, Oey O, Swarbrick N, Redfern A, Ong J, Gauci R, Low R, Hayne D. PMID: 38633828 [PubMed]
	The potential role of precision medicine to alleviate racial disparities in prostate, bladder and renal urological cancer care. BJUI Compass Sindhu KK, Dovey Z, Thompson M, Nehlsen AD, Skalina KA, Malachowska B, Hasan S, Guha C, Tang J, Salgado LR. PMID: 38633827 [PubMed]
	An early-onset specific polygenic risk score optimizes age-based risk estimate and stratification of prostate cancer: population-based cohort study. J Transl Med Cheng Y, Wu L, Xin J, Ben S, Chen S, Li H, Zhao L, Wang M, Cheng G, Du M. PMID: 38632662 [PubMed - in process]
	Tumor immune dysfunction and exclusion subtypes in bladder cancer and pan-cancer: a novel molecular subtyping strategy and immunotherapeutic prediction model. J Transl Med Zheng K, Hai Y, Chen H, Zhang Y, Hu X, Ni K. PMID: 38632658 [PubMed - in process]
	Impact of health and digital health literacy on quality of life following radical prostatectomy for prostate cancer: prospective single-center cohort study. World J Urol Keles A, Kose M, Somun UF, Culpan M, Yaksi N, Y. PMID: 38632212 [PubMed - in process]
	Re: Stereotactic Ablative Body Radiotherapy for Primary Kidney Cancer (TROG 15.03 FASTRACK II): A Non-randomised Phase 2 Trial. Eur Urol Jiang A, Liu Y, Cai C, Luo P, Wang L. PMID: 38631994 [PubMed - as supplied by publisher]
	Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma. N Engl J Med Choueiri TK, Tomczak P, Park SH, Venugopal B, Ferguson T, Symeonides SN, Hajek J, Chang YH, Lee JL, Sarwar N, Haas NB, Gurney H, Sawrycki P, Mahave M, Gross-Goupil M, Zhang T, Burke JM, Doshi G, Melichar B, Kopyltsov E, Alva A, Oudard S, Topart D, Hammers H, Kitamura H, McDermott DF, Silva A, Winquist E, Cornell J, Elfiky A, Burgents JE, Perini RF, Powles T, KEYNOTE-564 Investigators. PMID: 38631003 [PubMed - in process]
	Perioperative and Oncological Outcomes of Partial Versus Radical Nephrectomy for Complex Renal Tumors (RENAL Score â‰¥ 7): Systematic Review and Meta-Analysis. Ann Surg Oncol Zeng Z, Ge S, Li Y, Gan L, Meng C, Li K, Wang Z, Zheng L. PMID: 38630418 [PubMed - as supplied by publisher]
	A Japanese multi-institutional phase II study of moderate hypofractionated intensity-modulated radiotherapy with image-guided technique for prostate cancer. Int J Clin Oncol Nakamura K, Nihei K, Saito Y, Shikama N, Noda SE, Hara R, Imagumbai T, Mizowaki T, Akiba T, Kunieda E, Someya M, Ohga S, Kawamori J, Kozuka T, Ota Y, Inaba K, Kodaira T, Itoh Y, Funakoshi K, Kagami Y. PMID: 38630382 [PubMed - as supplied by publisher]
	A pictorial view on false positive findings of (68)Ga-PSMA-11 PET/CT and their prognostic value in patients with prostate carcinoma after radical prostatectomy and undetectable PSA values. Hell J Nucl Med Dancheva Z, Chausheva S, Stoeva T, Dyankova M, Yordanova T, Chaushev B, Marinov R, Nikolov V, Abushev P, Todorov G, Dimitrova E, Klisarova A, Anakievski D. PMID: 38629815 [PubMed - as supplied by publisher]
	Understanding and overcoming resistance to immunotherapy in genitourinary cancers. Cancer Biol Ther Evans ST, Jani Y, Jansen CS, Yildirim A, Kalemoglu E, Bilen MA. PMID: 38629578 [PubMed - indexed for MEDLINE]
	Predicting abiraterone efficacy in advanced prostate cancer: Insights from marker of proliferation Ki67. Prostate Zhao F, Zhao J, Wei X, Shi Y, Xu N, Zhu S, Chen J, Sun G, Dai J, Wang Z, Zhang X, Liang J, Hu X, Liu H, Zhao J, Liu Z, Nie L, Shen P, Chen N, Zeng H. PMID: 38629249 [PubMed - as supplied by publisher]
	Clinical and Radiological Factors for Predicting Clinically Significant Prostate Cancer in Biopsy-Naive Patients With PI-RADS 3 Lesions. Technol Cancer Res Treat Zhang Z, Hu C, Lin Y, Song O, Gong D, Zhang X, Wang N. PMID: 38629205 [PubMed - indexed for MEDLINE]
	Micro-RNA-371a-3p in Germ Cell Testicular Tumors on Diagnosis: A Prospective Case-Control Study in Turkish Population. Urol J K, Göger YE, Özkent MS, K, Okur Alt, Y, Karalezli G. PMID: 38629199 [PubMed - as supplied by publisher]
	Awareness and prevalence of self-reported benign prostatic hyperplasia: a cross-sectional study in Saudi Arabia. Front Public Health Alzahrani F, Madkhali OA, Khardali A, Alqahtani SS, Hijri AM, Alaqil MA, Madkhali YA, Otayn ZY, Syed NK. PMID: 38628856 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 169434

Seite 1 von 8472



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung